Benzinga | Aug 12, 2021 05:07PM EDT

Homology Medicines Q2 EPS $(0.54) Up From $(0.78) YoY, Sales $2.19M Up From $567.00K YoY

Homology Medicines (NASDAQ:FIXX) reported quarterly losses of $(0.54) per share. This is a 30.77 percent increase over losses of $(0.78) per share from the same period last year. The company reported $2.19 million in sales this quarter. This is a 285.71 percent increase over sales of $567.00 thousand the same period last year.